Evidence map›Paper›PMID 22829467›Full record

ArticleHuman mutation2012

Exploratory data from complete genomes of familial alzheimer disease age-at-onset outliers.

Matthew A Lalli, Gloria Garcia, Lucia Madrigal, Mauricio Arcos-Burgos, Mary Luz Arcila, Kenneth S Kosik, Francisco Lopera

Abstract read
In one paragraph

Article in Human mutation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Origin of the PSEN1 E280A mutation causing early-onset Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Matthew A LalliNeuroscience Research Institute, University of California at Santa Barbara, CA, USA.
Gloria Garcia
Lucia Madrigal
Mauricio Arcos-Burgos
Mary Luz Arcila
Kenneth S Kosik
Francisco Lopera
Universidad de Antioquia · COUniversity of California, Santa Barbara · US

Funding

Development of RNAi as Treatment for NeurodegenerationR01AG029802 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KOSIK, KENNETH STEPHEN · 2007 to 2011
$674k
Development of RNAi as Treatment for NeurodegenerationR21AG024063 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KOSIK, KENNETH STEPHEN · 2004 to 2005
$288k
NIA NIH HHS R01 AG029802NIA NIH HHS R21 AG024063
6 · The paper itself

Abstract

Identifying genes that modify the age at onset (AAO) of Alzheimer disease and targeting them pharmacologically represent a potential treatment strategy. In this exploratory study, we sequenced the complete genomes of six individuals with familial Alzheimer disease due to the autosomal dominant mutation p.Glu280Ala in PSEN1 (MIM# 104311; NM_000021.3:c.839A>C). The disease and its AAO are highly heritable, motivating our search for genetic variants that modulate AAO. The median AAO of dementia in carriers of the mutant allele is 49 years. Extreme phenotypic outliers for AAO in this genetically isolated population with limited environmental variance are likely to harbor onset modifying genetic variants. A narrow distribution of AAO in this kindred suggests large effect sizes of genetic determinants of AAO in these outliers. Identity by descent (IBD) analysis and a combination of bioinformatics filters have suggested several candidate variants for AAO modifiers. Future work and replication studies on these variants may provide mechanistic insights into the etiopathology of Alzheimer disease.

Indexed as

Age FactorsAlzheimer DiseaseChromosome MappingChromosomes, Human, Pair 1Chromosomes, Human, Pair 16Gene FrequencyGenetic Association StudiesGenome, HumanHumansMutation, MissenseOpen Reading FramesSequence Analysis, DNA

Identifiers

PMID22829467
PMCPMC3496074
OpenAlexW2078571392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.